Drugs / CLONICEL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00641329 | Feb 2008 → Feb 2009 | attention deficit-hyperactivity disorder | Addrenex Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CLONICEL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00641329 ↗ |
| Known as | clonidine HCl sustained release | “CLONICEL (clonidine HCl sustained release)” NCT00641329 ↗ |